RESEARCH

Pharmaceutical Economics,
Big Data Analysis & Policy Lab

Others

Clinical usefulness and cost-effectiveness study of cardiovascular drugs to reevaluate listed drugs
Author
Health Insurance Review and Assessment Service
Publication Date
2010